Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,514.00p
   
  • Change Today:
    -46.00p
  • 52 Week High: 1,634.00
  • 52 Week Low: 783.00
  • Currency: UK Pounds
  • Shares Issued: 86.04m
  • Volume: 36,112
  • Market Cap: £1,302.65m
  • RiskGrade: 125

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -6.5% 11.6%
ROCE n/a  
Latest F'cast
P/E n/a 90.1
PEG n/a n/a
Pr/Revenue 14.7 7.9
Pr/Book 11.4  
Latest F'cast
Revenue 36.9% 85.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OXB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 27.78 (20.31) (30.00)p n/a n/a n/a n/a 0.0%
31-Dec-17 37.59 (11.76) (725.00)p n/a n/a n/a n/a 0.0%
31-Dec-18 66.78 5.01 11.57p 61.1 n/a n/a n/a 0.0%
31-Dec-19 64.06 (20.89) (22.10)p n/a n/a n/a n/a 0.0%
31-Dec-20 87.73 (6.57) (7.81)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OXB Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 162.45 18.79 21.95p 71.1 n/a n/a n/a 0.0%
31-Dec-22 133.80 14.58 16.54p 94.3 n/a -25% n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

OXB Company Announcements

Strategic investment by Serum Life Sciences 22-Sep-2021 07:38 RNS
Interim Results 22-Sep-2021 07:00 RNS
Total Voting Rights 01-Sep-2021 10:48 RNS

Latest OXB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

OXB Market Data

Currency UK Pounds
Share Price 1,514.00p
Change Today -46.00p
% Change -2.95 %
52 Week High 1,634.00
52 Week Low 783.00
Volume 36,112
Shares Issued 86.04m
Market Cap £1,302.65m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
77.02% below the market average77.02% below the market average77.02% below the market average77.02% below the market average77.02% below the market average
64% below the sector average64% below the sector average64% below the sector average64% below the sector average64% below the sector average
Price Trend
94.10% above the market average94.10% above the market average94.10% above the market average94.10% above the market average94.10% above the market average
80.65% above the sector average80.65% above the sector average80.65% above the sector average80.65% above the sector average80.65% above the sector average
Income Not Available
Growth
49.35% above the market average49.35% above the market average49.35% above the market average49.35% above the market average49.35% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 27-Sep-2021

Time Volume / Share Price
11:00 166 @ 1,514.06p
10:58 579 @ 1,511.64p
10:58 9 @ 1,514.68p
10:54 100 @ 1,514.00p
10:54 150 @ 1,515.09p

OXB Key Personnel

CEO John Dawson
CFO Stuart Paynter

Top of Page